Elicio Therapeutics, Inc. (ELTX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-2418.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $2.30M | $28.31M | $2.88M | — |
| Cost of Revenue | — | — | — | $0 | $433.0K | $1.19M | — |
| Operating Income | -$37.71M | -$44.99M | -$35.74M | -$23.73M | -$39.31M | -$55.27M | — |
| Net Income | -$39.57M | -$51.90M | -$35.20M | -$28.21M | -$54.57M | -$80.11M | — |
| EPS (Diluted) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 | — |
| Total Assets | $25.86M | $28.18M | $27.15M | $22.66M | $96.51M | $47.35M | — |
| Total Liabilities | $24.23M | $39.49M | $15.77M | $13.75M | $15.01M | $137.80M | — |
| Shareholders' Equity | $1.64M | -$11.31M | $11.37M | -$102.14M | -$74.54M | -$90.45M | -$18.59M |
| Cash & Equivalents | $18.56M | $17.62M | $12.89M | $6.16M | $88.76M | $34.61M | — |
| Operating Cash Flow | -$36.95M | -$37.07M | -$32.69M | -$22.18M | -$52.64M | -$22.89M | — |
| Capital Expenditures | $16.0K | $87.0K | $66.0K | $654.0K | $382.0K | $41.0K | — |
| Shares Outstanding | 17.80M | 11.03M | 9.60M | 320.3K | 29.96M | 15.32M | — |